Inke is a leading global developer and manufacturer of micronized inhalation active pharmaceutical ingredients (API) for the treatment of respiratory illnesses

Established in 1980 and based near Barcelona, Spain, Inke has more than 25 years of experience, with a strong focus on the development and manufacturing of micronized APIs. In particular, the company has specialized expertise in APIs for the treatment of respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD).
Inke is a key partner to major pharmaceuticals companies worldwide, having twelve respiratory APIs for inhalation in its portfolio and distributing its products to more than 40 countries including Europe, the US, and Asia.
The Company also benefits from a highly scientific employee base and a flawless audit and compliance track record.



Investment Year